Related Experiment Video
Updated: Aug 27, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Tuberculosis and Cardiovascular Complications: An Overview
Mayowa A Adefuye1, Nisha Manjunatha2, Vinutna Ganduri3
1Research, University of Ibadan College of Medicine, Ibadan, NGA.
Tuberculosis (TB), caused by Mycobacterium tuberculosis, significantly impacts the cardiovascular system, leading to high mortality, especially in low-income regions. Further research is needed to understand and treat these complex cardiovascular complications.
Area of Science:
- Infectious Diseases
- Cardiology
- Public Health
Background:
- Tuberculosis (TB) remains a leading infectious cause of mortality globally.
- Cardiovascular diseases (CVS) are the primary cause of death worldwide, particularly in low and middle-income countries.
- High TB mortality rates overlap with high cardiovascular disease burdens, exacerbating risks.
Purpose of the Study:
- To review the pathophysiology of cardiovascular complications in TB.
- To highlight mechanisms, common complications, management, and prognostic factors.
- To identify research gaps in understanding TB's cardiovascular impact.
Main Methods:
- Literature review focusing on TB and cardiovascular system interactions.
- Analysis of pathophysiological mechanisms.
- Synthesis of current management and prognostic data.
Main Results:
- TB affects multiple organ systems, including the cardiovascular system.
- Common complications include pericarditis; rarer forms involve myocarditis, coronary artery disease, and aortitis.
- Multisystemic TB involvement significantly increases cardiovascular mortality.
Conclusions:
- Cardiovascular complications of TB are diverse and contribute to high mortality.
- Rarer complications require a high index of suspicion for diagnosis and management.
- Further research is essential to elucidate causal mechanisms and optimize treatment strategies.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: